Taro Pharma, the subsidiary of pharmaceutical major Sun Pharma on October 27, reported a net profit of $8.5 million for the July-September quarter. The company had posted a net loss of $2.8 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback